Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 13.80%368.22B | 6.63%1.63T | 80.56%285.24B | -1.51%585.97B | 17.25%431.63B | -19.95%323.57B | -8.57%1.53T | -30.81%157.97B | 29.79%594.98B | -35.05%368.14B |
Net profit before non-cash adjustment | 15.55%200.57B | -9.76%590.27B | 292.09%87.59B | -64.74%129.86B | 69.20%199.23B | 19.11%173.58B | 13.68%654.13B | -78.15%22.34B | 195.78%368.3B | -34.31%117.75B |
Total adjustment of non-cash items | 38.76%250.03B | 14.34%1.03T | 1.87%289.35B | 190.24%320.12B | -16.88%240.63B | -17.06%180.18B | -16.15%901.11B | 4.16%284.05B | -61.44%110.29B | 6.71%289.51B |
-Depreciation and amortization | 0.25%186.95B | -2.67%743.81B | -6.79%183.06B | -1.84%189.08B | -1.59%185.19B | -0.29%186.48B | 2.54%764.21B | 5.28%196.41B | -1.73%192.62B | 4.55%188.17B |
-Reversal of impairment losses recognized in profit and loss | ---- | -44.44%25.13B | 598.72%25.13B | ---- | ---- | ---- | 53.82%45.23B | 619.20%3.6B | 8.31%31.3B | ---- |
-Share of associates | 99.93%-8M | -96.32%1.76B | -36.02%9.8B | -423.20%-14.92B | 1.22%19.06B | -233.57%-12.17B | -20.33%47.88B | -25.06%15.31B | -69.50%4.62B | 21.33%18.83B |
-Disposal profit | -1,738.68%-43.43B | 103.40%9.81B | -68.68%6.07B | 108.75%26.72B | -740.65%-25.62B | 6,363.41%2.65B | -2,186.67%-288.92B | 443.56%19.37B | -5,665.80%-305.28B | 73.35%-3.05B |
-Deferred income tax | -2.26%73.34B | 3.31%215.65B | 72.18%27.86B | 30.44%59.63B | -30.60%53.12B | 6.74%75.04B | -26.13%208.74B | -64.01%16.18B | -13.37%45.71B | -6.42%76.55B |
-Other non-cash items | 146.19%33.17B | -72.47%34.13B | 12.83%37.44B | -57.81%59.62B | 769.03%8.88B | -45.92%-71.81B | 511.95%123.97B | 28.10%33.19B | 1,252.17%141.33B | -124.44%-1.33B |
Changes in working capital | -172.81%-82.37B | 119.60%5.86B | 38.21%-91.71B | 16.85%136B | 78.96%-8.23B | -173.22%-30.19B | -263.95%-29.91B | -1.20%-148.41B | 143.25%116.39B | -133.65%-39.13B |
-Change in receivables | -56.78%48.28B | -158.86%-325.14B | -276.46%-100.99B | 36.07%-154.53B | -360.60%-181.33B | 13.69%111.71B | 25.80%-125.61B | 157.54%57.23B | -1.48%-241.73B | -184.74%-39.37B |
-Change in inventory | -1,977.44%-25.38B | 112.86%2.74B | 82.65%17.97B | -516.07%-10.02B | 80.90%-6.56B | 80.03%1.35B | -28.99%-21.33B | 24.37%9.84B | 109.49%2.41B | -294.03%-34.33B |
-Change in prepaid assets | -23.21%47.16B | 158.72%170.9B | -19.22%17.63B | 760.95%73.48B | 176.29%18.38B | -22.69%61.42B | -72.55%66.06B | 9.12%21.82B | -111.73%-11.12B | -139.36%-24.09B |
-Change in payables | 37.65%-111.09B | 4.15%292.55B | 132.60%23.6B | -33.95%253.54B | 132.81%193.59B | -56.66%-178.17B | 459.57%280.89B | -51.39%-72.37B | 60.38%383.83B | 112.72%83.15B |
-Changes in other current assets | -56.00%-41.34B | 41.20%-135.19B | 69.74%-49.91B | ---- | ---- | -12.84%-26.5B | -164.97%-229.91B | -504.29%-164.93B | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -27.62%-17.99B | -2.54%-62.92B | -17.58%-19.15B | 3.33%-14.01B | 5.53%-15.66B | -0.69%-14.1B | 3.21%-61.36B | -2.87%-16.29B | 13.20%-14.5B | -1.05%-16.58B |
Interest received (cash flow from operating activities) | 274.87%5.06B | -9.79%6.54B | 87.81%1.5B | -26.26%1.33B | -9.30%2.37B | -33.94%1.35B | 2.08%7.25B | -24.05%796M | 7.39%1.8B | 85.65%2.61B |
Tax refund paid | 37.04%-80.23B | -5.84%-281.18B | 84.35%-3.17B | -29.17%-160.01B | 92.05%9.43B | -0.76%-127.43B | 25.69%-265.66B | -45.14%-20.22B | 4.62%-123.88B | 1,184.82%4.91B |
Other operating cash inflow (outflow) | 4.82%-10.71B | 1.28%-49.16B | 5.59%-14.11B | 22.23%-10.87B | -3.92%-12.93B | -33.42%-11.26B | -28.89%-49.8B | -14.16%-14.95B | -83.32%-13.97B | -23.93%-12.44B |
Operating cash flow | 53.56%264.35B | 7.26%1.24T | 133.26%250.3B | -9.46%402.41B | 19.67%414.84B | -33.11%172.14B | -4.95%1.16T | -42.46%107.31B | 45.29%444.43B | -36.06%346.64B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -11.63%-186.85B | 9.10%-552.24B | 24.80%-100.18B | 13.49%-134.82B | 6.73%-149.85B | -6.07%-167.39B | 14.07%-607.55B | -12.39%-133.23B | -26.33%-155.85B | 52.82%-160.66B |
Net business purchase and sale | ---23.13B | -117.66%-67.53B | -661.74%-67.53B | -98.32%6.69B | ---- | ---- | 29,564.95%382.46B | -465.37%-8.87B | --397.29B | ---- |
Net investment product transactions | -42.62%-94.9B | -5,610.17%-272.89B | 10.57%-52.71B | -339.06%-60.76B | -410.27%-92.87B | -5,473.28%-66.55B | 97.95%-4.78B | -234.69%-58.94B | 226.92%25.42B | 127.80%29.93B |
Net changes in other investments | 35.01%-13.81B | -146.55%-34.95B | -241.88%-11.4B | -204.16%-4.71B | -96.06%2.41B | -1,755.06%-21.25B | 550.55%75.1B | 158.59%8.04B | 1,120.99%4.52B | 242.08%61.25B |
Investing cash flow | -24.89%-318.69B | -499.33%-927.61B | -20.12%-231.82B | -171.34%-193.61B | -227.37%-247B | -61.79%-255.18B | 83.84%-154.77B | -114.27%-192.99B | 288.68%271.39B | 82.47%-75.45B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 181.68%167.68B | 127.60%22.7B | -43.37%-174.23B | 432.96%104.43B | 124.95%32.97B | -60.80%59.53B | -153.80%-82.26B | 38.81%-121.53B | -88.80%19.59B | 57.54%-132.18B |
Net common stock issuance | --7.42B | --36.23B | ---36.55B | --66.21B | ---- | ---- | --0 | --0 | ---- | ---- |
Cash dividends paid | -0.09%-201.4B | -0.29%-406.75B | 7.54%-1.03B | -0.12%-202.38B | 25.35%-2.13B | -0.88%-201.21B | -0.48%-405.56B | 7.93%-1.11B | -0.61%-202.14B | 3.71%-2.85B |
Cash dividends for minorities | -13.86%-24.77B | 3.21%-45.7B | -13.37%-1.54B | -440.96%-20.97B | 92.90%-1.43B | 0.47%-21.75B | 26.46%-47.21B | 95.59%-1.36B | -10.36%-3.88B | -98.01%-20.12B |
Net other fund-raising expenses | -204.68%-19.49B | -8.45%36.42B | 114.63%20.44B | 75.12%29.87B | -411.41%-32.51B | 576.49%18.62B | 304.38%39.78B | -28.14%9.52B | 1,339.49%17.06B | -27.87%10.44B |
Financing cash flow | 51.28%-70.55B | 27.90%-357.1B | -68.52%-192.91B | 86.51%-22.85B | 102.41%3.48B | -117.07%-144.82B | -62.34%-495.26B | 47.36%-114.48B | -498.77%-169.36B | 53.31%-144.7B |
Other cash adjustments within cash changes | --33.01B | ---33.01B | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net cash flow | ||||||||||
Beginning cash position | -3.22%1.99T | 33.13%2.06T | -2.80%2.19T | 17.18%2.01T | 15.82%1.84T | 33.13%2.06T | -2.40%1.55T | 35.77%2.26T | 12.43%1.72T | -7.94%1.59T |
Current changes in cash | 59.68%-91.88B | -115.43%-78.03B | -3.64%-207.44B | -65.97%185.95B | 35.45%171.33B | -791.97%-227.86B | 1,179.51%505.72B | -65.38%-200.16B | 308.50%546.46B | 163.86%126.49B |
Effect of exchange rate changes | -15.93%5.92B | 76.22%11.73B | 349.30%5.43B | 49.52%-2.41B | -38.86%1.67B | -5.98%7.04B | -23.88%6.66B | -73.72%1.21B | -272.57%-4.77B | 305.65%2.73B |
End cash Position | 3.73%1.91T | -3.22%1.99T | -3.22%1.99T | -2.80%2.19T | 17.18%2.01T | 15.82%1.84T | 33.13%2.06T | 33.13%2.06T | 35.77%2.26T | 12.43%1.72T |
Free cash flow | 1,608.89%76.92B | 25.45%685.62B | 654.56%148.77B | -7.24%267.51B | 42.54%264.83B | -95.46%4.5B | 7.83%546.53B | -139.84%-26.83B | 59.02%288.38B | -7.82%185.8B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |